These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15308178)

  • 1. Boron biodistribution in beagles after intravenous infusion of 4-dihydroxyborylphenylalanine-fructose complex.
    Kulvik ME; Vähätalo JK; Benczik J; Snellman M; Laakso J; Hermans R; Järviluoma E; Rasilainen M; Färkkilä M; Kallio ME
    Appl Radiat Isot; 2004 Nov; 61(5):975-9. PubMed ID: 15308178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodistribution of boron after intravenous 4-dihydroxyborylphenylalanine-fructose (BPA-F) infusion in meningioma and schwannoma patients: A feasibility study for boron neutron capture therapy.
    Kulvik M; Kallio M; Laakso J; Vähätalo J; Hermans R; Järviluoma E; Paetau A; Rasilainen M; Ruokonen I; Seppälä M; Jääskeläinen J
    Appl Radiat Isot; 2015 Dec; 106():207-12. PubMed ID: 26298436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodistribution studies of boronophenylalanine-fructose in melanoma and brain tumor patients in Argentina.
    Liberman SJ; Dagrosa A; Jiménez Rebagliati RA; Bonomi MR; Roth BM; Turjanski L; Castiglia SI; González SJ; Menéndez PR; Cabrini R; Roberti MJ; Batistoni DA
    Appl Radiat Isot; 2004 Nov; 61(5):1095-100. PubMed ID: 15308198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
    Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
    Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE
    Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boron biodistribution study in colorectal liver metastases patients in Argentina.
    Cardoso J; Nievas S; Pereira M; Schwint A; Trivillin V; Pozzi E; Heber E; Monti Hughes A; Sanchez P; Bumaschny E; Itoiz M; Liberman S
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S76-9. PubMed ID: 19375931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose.
    Timonen M; Kankaanranta L; Lundbom N; Collan J; Kangasmäki A; Kortesniemi M; Häkkinen AM; Lönngren A; Karjalainen S; Rasilainen M; Leinonen J; Huitti T; Jääskeläinen J; Kouri M; Savolainen S; Heikkinen S
    Eur J Radiol; 2005 Nov; 56(2):154-9. PubMed ID: 16233888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Boron Neutron Capture Therapy for glioblastoma multiforme: advantage of prolonged infusion of BPA-f.
    Sköld K; H-Stenstam B; Diaz AZ; Giusti V; Pellettieri L; Hopewell JW
    Acta Neurol Scand; 2010 Jul; 122(1):58-62. PubMed ID: 19951268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo (19)F MRI and (19)F MRS of (19)F-labelled boronophenylalanine-fructose complex on a C6 rat glioma model to optimize boron neutron capture therapy (BNCT).
    Porcari P; Capuani S; D'Amore E; Lecce M; La Bella A; Fasano F; Campanella R; Migneco LM; Pastore FS; Maraviglia B
    Phys Med Biol; 2008 Dec; 53(23):6979-89. PubMed ID: 19001698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution of boron in dogs with spontaneous intracranial tumors following borocaptate sodium administration.
    Kraft SL; Gavin PR; Leathers CW; DeHaan CE; Bauer WF; Miller DL; Dorn RV; Griebenow ML
    Cancer Res; 1994 Mar; 54(5):1259-63. PubMed ID: 8118814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity, biodistribution, and convection-enhanced delivery of the boronated porphyrin BOPP in the 9L intracerebral rat glioma model.
    Ozawa T; Afzal J; Lamborn KR; Bollen AW; Bauer WF; Koo MS; Kahl SB; Deen DF
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):247-52. PubMed ID: 16111595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
    Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
    Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer.
    Ichikawa H; Taniguchi E; Fujimoto T; Fukumori Y
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S111-4. PubMed ID: 19376721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy.
    Zuo CS; Prasad PV; Busse P; Tang L; Zamenhof RG
    Med Phys; 1999 Jul; 26(7):1230-6. PubMed ID: 10435522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
    H-Stenstam B
    Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of L-10B-p-boronophenylalanine-fructose and the boron neutron capture reaction on mouse brain dopaminergic neurons.
    Setiawan Y; Halliday GM; Harding AJ; Moore DE; Allen BJ
    Cancer Res; 1995 Feb; 55(4):874-7. PubMed ID: 7850802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of boron concentrations in blood from patients on boron neutron capture therapy.
    Shibata Y; Matsumura A; Yamamoto T; Akutsu H; Yasuda S; Nakai K; Nose T; Yamamoto K; Kumada H; Hori N; Ohtake S
    Anticancer Res; 2003; 23(6D):5231-5. PubMed ID: 14981995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced blood boron concentration estimation for BPA-F mediated BNCT.
    Kortesniemi M; Seppälä T; Auterinen I; Savolainen S
    Appl Radiat Isot; 2004 Nov; 61(5):823-7. PubMed ID: 15308151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam.
    Kiger WS; Lu XQ; Harling OK; Riley KJ; Binns PJ; Kaplan J; Patel H; Zamenhof RG; Shibata Y; Kaplan ID; Busse PM; Palmer MR
    Appl Radiat Isot; 2004 Nov; 61(5):1075-81. PubMed ID: 15308195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pharmacokinetic model for the concentration of 10B in blood after boronophenylalanine-fructose administration in humans.
    Kiger WS; Palmer MR; Riley KJ; Zamenhof RG; Busse PM
    Radiat Res; 2001 Apr; 155(4):611-8. PubMed ID: 11260663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.